Thomas Kosten, MD

Thomas Kosten, MD

Neurology Houston, TX

Professor, Psychiatry, Baylor College of Medicine


Office Address

  • 2002 Holcombe Blvd
    Va Bldg 110, Room 229
    Houston, TX 77030
    Phone: (713) 794-7032

Thomas Kosten, MD

Neurology Houston, TX

Professor, Psychiatry, Baylor College of Medicine

Clinical Specialties & Interests

  • Neurology: Addiction Medicine

Education & Training

  • Yale-New Haven HospitalYale-New Haven Hospital
  • Yale University School of Medicine
  • Yale-New Haven HospitalYale-New Haven Hospital
  • Weill Cornell Medical College of Cornell UniversityWeill Cornell Medical College of Cornell University

Certifications & Licensure

  • TX State Medical LicenseTX State Medical License2007 - 2016
  • CT State Medical LicenseCT State Medical License1979 - 2016
  • American Board of Psychiatry and NeurologyPsychiatry
  • American Board of Psychiatry and NeurologyAddiction Psychiatry

Awards, Honors, & Recognition

  • Whos Who in Medicine and HealthcareMarquis Whos Who

Clinical Trials

Publications & Presentations

PubMed

Grant Support

  • Human Methamphetamine Vaccine: Translational Avante Garde AwardNational Institute On Drug Abuse
    2011 - 2011
  • Methadone StudiesNational Institute On Drug Abuse
    2009 - 2011
  • Stimulant Pharmacotherapy: Noradrenergic TargetsNational Institute On Drug Abuse
    2009 - 2011
  • Developing Immunotherapeutics For Methamphetamine AbuseNational Institute On Drug Abuse
    2009 - 2010
  • Clinical Methods CoreNational Institute On Drug Abuse
    2009 - 2011
  • Multisite Controlled Trial Of Cocaine Vaccine (1of 6) LEAD Site/ Houston TreatmenNational Institute On Drug Abuse
    2008 - 2012
  • Pharmacotherapies Of Cocaine Addiction In HumansNational Institute On Drug Abuse
    2007 - 2007
  • Administrative And Scientific CoreNational Institute On Drug Abuse
    2007 - 2008
  • Tropisetron With Risperidone For SchizophreniaNational Institute Of Mental Health
    2007 - 2009
  • Cocaine Pharmacotherapy Targeting Dopamine &GabaNational Institute On Drug Abuse
    2006 - 2008
  • Comorbidity In Cocaine And Opioid PharmacotherapyNational Institute On Drug Abuse
    2006 - 2010
  • Heroin Addiction Treatment: Naltrexone And LofexidineNational Institute On Drug Abuse
    2006 - 2007
  • Comorbidity In Cocaine And Opioid PharmacotherapyNational Institute On Drug Abuse
    2005 - 2005
  • Kappa Opioid Antagonist For Cocaine AddictionNational Institute On Drug Abuse
    2005 - 2011
  • Heroin Addiction Treatment: Naltrexone And LofexidineNational Institute On Drug Abuse
    2004 - 2005
  • Cocaine Pharmacotherapy Targeting Dopamine &GabaNational Institute On Drug Abuse
    2004 - 2005
  • Scientific And Administrative CoreNational Institute On Drug Abuse
    2004 - 2004
  • FMRI Of Gender And Stress Response In Cocaine DependenceNational Institute On Drug Abuse
    2002 - 2002
  • Cocaine Vaccine For Methadone Maintained PatientsNational Institute On Drug Abuse
    2002 - 2004
  • Pharmacotherapy For Opioid And Cocaine DependenceNational Institute On Drug Abuse
    2001 - 2004
  • Immunological Agents For Cocaine AbuseNational Institute On Drug Abuse
    2000 - 2002
  • Comorbidity In Cocaine And Opioid PharmacotherapyNational Institute On Drug Abuse
    2000 - 2004
  • Active Immunization To Develop Antibodies To CocaineNational Institute On Drug Abuse
    2000 - 2002
  • 11th - 15th Annual Meetings And SymposiaNational Institute On Drug Abuse
    2000 - 2001
  • Therapeutic Cocaine VaccineNational Institute On Drug Abuse
    2000 - 2002
  • Core--Medication Development Research CenterNational Institute On Drug Abuse
    1999 - 2002
  • Clopidogrel &Isradipine For Brian Perfusion Defects In Cocaine AbusersNational Institute On Drug Abuse
    1999 - 2002
  • Cocaine Pharmacotherapies For Comorbid PopulationsNational Institute On Drug Abuse
    1999 - 2003
  • 9th/13th Annual Meeting And SymposiumNational Institute On Drug Abuse
    1998 - 1999
  • Immunological Agents For Cocaine AbuseNational Institute On Drug Abuse
    1997 - 1998
  • Active Immunization To Develop Antibodies To CocaineNational Institute On Drug Abuse
    1997 - 1998
  • Cocaine Discrimination In Humans--Effects Of Dopaminergic AgentsNational Institute On Drug Abuse
    1996 - 1997
  • Non-Opioid Neurobiology Of Opioid DependenceNational Institute On Drug Abuse
    1996 - 1997
  • Core--CoreNational Institute On Drug Abuse
    1996 - 1998
  • Agonist To Antagonist--New ApproachesNational Institute On Drug Abuse
    1994 - 1995
  • Reducing AIDS RisksNational Institute On Drug Abuse
    1994 - 1994
  • Yale Medications Development Research CenterNational Institute On Drug Abuse
    1994 - 1998
  • Small Instrumentation GrantNational Institute On Drug Abuse
    1993 - 1993
  • Matching Methadone Patients To Psychosocial TreatmentNational Institute On Drug Abuse
    1993 - 1994
  • The Yale University Substance Abuse Research CenterNational Institute On Drug Abuse
    1991 - 1991
  • Clinical Research Center For Opioid And Cocaine AbuseNational Institute On Drug Abuse
    1991 - 1999
  • Treatment Research Unit--Reducing AIDS RisksNational Institute On Drug Abuse
    1989 - 1993
  • Buprenorphine Maintenance For Opioid AddictsNational Institute On Drug Abuse
    1988 - 2000
  • Agonist To Antagonist: New ApproachesNational Institute On Drug Abuse
    1987 - 1993
  • Pharmacotherapy Of IV Cocaine Use In Methadone PatientsNational Institute On Drug Abuse
    1987 - 1989

Professional Memberships

  • The full profile is locked and available to verified physicians only.
    Join over 50% of U.S. physicians already on Doximity and get access to this and over 700,000 physician CVs. Find your physician profile

Physicians, view Dr. Kosten's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV

© 2015 Doximity, Inc.GroupsHelpBlogCompanyContactPrivacyDirectory